Predicting transition to chronic pain

Current Opinion in Neurology

Volumn 26, Issue 4, 2013, Pages 360-367

  Vania Apkarian, A ^a   Baliki, Marwan N ^a   Farmer, Melissa A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

addiction; brain reorganization; functional MRI; sensitization

Indexed keywords

BACKACHE; BRAIN FUNCTION; CHRONIC PAIN; ELECTROENCEPHALOGRAM; GENETIC RISK; HUMAN; LONGITUDINAL STUDY; LOW BACK PAIN; NEUROIMAGING; NOCICEPTION; NUCLEUS ACCUMBENS; PREDICTION; PREFRONTAL CORTEX; REVIEW; SOCIAL PSYCHOLOGY;

BRAIN; CHRONIC PAIN; HUMANS; NEUROIMAGING; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84880750403     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32836336ad     Document Type: Review

References (67)

1. Frymoyer JW. Back pain and sciatica. N Engl J Med 1988; 318:291-300. (Pubitemid 18034521)
2. Andersson GBJ, Frymoyer JW. The epidemiology of spinal disorders. In: The adult spine: principles and practice, Vol 2. Philadelphia, PA: Lippincott-Raven; 1997. pp. 93-141.
3. Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine 1995; 20:11-19.
4. Praemer A, Furnes S, Rice DP. Musculoskeletal conditions in the United States, Vol 1. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1992. pp. 1-99.
5. Deyo RA. Low-back pain. Sci Am 1998; 279:48-53.
6. van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000; 25:2501-2513.
7. Coats TL, Borenstein DG, Nangia NK, Brown MT. Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial 1. Clin Ther 2004; 26:1249-1260. (Pubitemid 39445347)
8. Pallay RM, Seger W, Adler JL, et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 2004; 33:257-266. (Pubitemid 39180171)
9. Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 2003; 28:2540-2545. (Pubitemid 37448972)
10. Bogduk N. Pharmacological alternatives for the alleviation of back pain. Expert Opin Pharmacother 2004; 5:2091-2098. (Pubitemid 39406111)
11. Ehrlich GE. Low back pain. Bull World Health Organ 2003; 81:671-676. (Pubitemid 37254689)
12. van den Bosch MA, Hollingworth W, Kinmonth AL, Dixon AK. Evidence against the use of lumbar spine radiography for low back pain. Clin Radiol 2004; 59:69-76. (Pubitemid 38054736)
13. Willburger RE, Ehiosun UK, Kuhnen C, et al. Clinical symptoms in lumbar disc herniations and their correlation to the histological composition of the extruded disc material. Spine 2004; 29:1655-1661. (Pubitemid 39014844)
14. Okuda T, Baba I, Fujimoto Y, et al. The pathology of ligamentum flavum in degenerative lumbar disease. Spine 2004; 29:1689-1697. (Pubitemid 39014850)
15. MacGregor AJ, Andrew T, Sambrook PN, Spector TD. Structural, psychological, and genetic influences on low back and neck pain: a study of adult female twins. Arthritis Rheum 2004; 51:160-167. (Pubitemid 38468697)
16. Sambrook PN, MacGregor AJ, Spector TD. Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis Rheum 1999; 42:366-372. (Pubitemid 29072855)
17. Hartvigsen J, Christensen K, Frederiksen H, Petersen HC. Genetic and environmental contributions to back pain in old age: a study of 2,108 Danish twins aged 70 and older. Spine 2004; 29:897-901. (Pubitemid 38480975)
18. Manek NJ, MacGregor AJ. Epidemiology of back disorders: prevalence, risk factors, and prognosis. Curr Opin Rheumatol 2005; 17:134-140. (Pubitemid 40279606)
19. Meyer T, Cooper J, Raspe H. Disabling low back pain and depressive symptoms in the community-dwelling elderly: a prospective study. Spine 2007; 32:2380-2386. (Pubitemid 47508849)
20. Reid MC, Williams CS, Gill TM. The relationship between psychological factors and disabling musculoskeletal pain in community-dwelling older persons. J Am Geriatr Soc 2003; 51:1092-1098. (Pubitemid 36993465)
21. Schultz IZ, Crook J, Meloche GR, et al. Psychosocial factors predictive of occupational low back disability: towards development of a return-to-work model. Pain 2004; 107:77-85. (Pubitemid 38063134)
22. Fransen M, Woodward M, Norton R, et al. Risk factors associated with the transition from acute to chronic occupational back pain. Spine 2002; 27:92-98. (Pubitemid 34219534)
23. Feldman DE, Rossignol M, Shrier I, Abenhaim L. Smoking. A risk factor for development of low back pain in adolescents. Spine 1999; 24:2492-2496. (Pubitemid 30002986)
24. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000; 85:317-332. (Pubitemid 30214160)
25. Woods MP, Asmundson GJ. Evaluating the efficacy of graded in vivo exposure for the treatment of fear in patients with chronic back pain: a randomized controlled clinical trial. Pain 2007; 136:271-280.
26. Keeley P, Creed F, Tomenson B, et al. Psychosocial predictors of healthrelated quality of life and health service utilisation in people with chronic low back pain. Pain 2007; 135:142-150. (Pubitemid 351186796)
27. Clays E, De Bacquer D, Leynen F, et al. The impact of psychosocial factors on low back pain: longitudinal results from the Belstress study. Spine 2007; 32:262-268. (Pubitemid 46105814)
28. Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 2004; 24:10410-10415. (Pubitemid 39552626)
29. Apkarian AV, Sosa Y, Krauss BR, et al. Chronic pain patients are impaired on an emotional decision-making task. Pain 2004; 108:129-136. (Pubitemid 38251682)
30. Baliki MN, Chialvo DR, Geha PY, et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci 2006; 26:12165-12173. (Pubitemid 44808383)
31. Baliki MN, Geha PY, Fields HL, Apkarian AV. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 2010; 66:149-160.
32. Baliki MN, Petre B, Torbey S, et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci 2012; 15:1117-1119.
33. Centeno MV, Mutso A, Millecamps M, Apkarian AV. Prefrontal cortex and spinal cord mediated antineuropathy and analgesia induced by sarcosine, a glycine-T1 transpoter inhibitor. Pain 2009; 145:176-183.
34. Metz AE, Yau HJ, Centeno MV, et al. Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain. Proc Natl Acad Sci USA 2009; 106:2423-2428.
35. Millecamps M, Centeno MV, Berra HH, et al. D-cycloserine reduces neuropathic pain behavior through limbic NMDA-mediated circuitry. Pain 2007; 132:108-123. (Pubitemid 47494564)
36. Mutso AA, Radzicki D, Baliki MN, et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci 2012; 32:5747-5756.
37. Apkarian AV, Lavarello S, Randolf A, et al. Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain. Neurosci Lett 2006; 407:176-181. (Pubitemid 44397245)
38. Johansen JP, Fields HL. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat Neurosci 2004; 7:398-403. (Pubitemid 38429180)
39. Qu C, King T, Okun A, et al. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain 2011; 152:1641-1648.
40. Sarkis R, Saade N, Atweh S, et al. Chronic dizocilpine or apomorphine and development of neuropathy in two rat models I: behavioral effects and role of nucleus accumbens. Exp Neurol 2011; 228:19-29.
41. Gear RW, Levine JD. Nucleus accumbens facilitates nociception. Exp Neurol 2011; 229:502-506.
42. Baliki M, Katz J, Chialvo DR, Apkarian AV. Single subject pharmacological-MRI (phMRI) study: modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor. Mol Pain 2005; 1:32.
43. Baliki MN, Geha PY, Jabakhanji R, et al. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain 2008; 4:47.
44. Farmer MA, Chanda ML, Parks EL, et al. Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol 2011; 186:117-124.
45. Geha PY, Baliki MN, Chialvo DR, et al. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain 2007; 128:88-100. (Pubitemid 46216604)
46. Geha PY, Baliki MN, Wang X, et al. Brain dynamics for perception of tactile allodynia (touch-induced pain) in postherpetic neuralgia. Pain 2008; 38:641-656.
47. Geha PY, Baliki MN, Harden RN, et al. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 2008; 60:570-581.
48. Apkarian AV. Pain perception in relation to emotional learning. Curr Opin Neurobiol 2008; 18:464-468.
49. Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol 2009; 87:81-97.
50. Apkarian AV, Hashmi JA, Baliki MN. Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain 2011; 152:s49-s64.
51. Fields HL. A motivation-decision model of pain: the role of opioids. In: Proceedings of the 11th World Congress on Pain. Seattle, WA: IASP press; 2006. pp. 449-459.
52. Glimcher PW. Decisions, uncertainty, and the brain: the science of neuroeconomics. Cambridge, MA: MIT press; 2003.
53. Glimcher PW, Camerer CF, Fehr E, Poldrack RA. Neuroeconomics. London, UK: Elsevier; 2009.
54. Rolls ET. Emotion explained. Oxford: Oxford University Press; 2005.
55. Goeders NE, Smith JE. Cortical dopaminergic involvement in cocaine reinforcement. Science 1983; 221:773-775. (Pubitemid 13030639)
56. Ambroggi F, Ishikawa A, Fields HL, Nicola SM. Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons. Neuron 2008; 59:648-661.
57. Carlezon WA Jr, Thomas MJ. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 2009; 56 (Suppl 1):122-132.
58. Becerra L, Breiter HC, Wise R, et al. Reward circuitry activation by noxious thermal stimuli. Neuron 2001; 32:927-946. (Pubitemid 34024851)
59. Seymour B, O'Doherty JP, Dayan P, et al. Temporal difference models describe higher-order learning in humans. Nature 2004; 429:664-667. (Pubitemid 38812318)
60. Seymour B, O'Doherty JP, Koltzenburg M, et al. Opponent appetitive-aversive neural processes underlie predictive learning of pain relief. Nat Neurosci 2005; 8:1234-1240. (Pubitemid 43348143)
61. Navratilova E, Xie JY, Okun A, et al. Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci USA 2012; 109:20709-20713.
62. Wanigasekera V, Lee MC, Rogers R, et al. Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects. Proc Natl Acad Sci USA 2012; 109: 17705-17710.
63. Koob GF. Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 1992; 654:171-191.
64. Volkow ND, Wang GJ, Fowler JS, et al. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays 2010; 32:748-755.
65. Hikida T, Kimura K, Wada N, et al. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 2010; 66:896-907.
66. Hikida T, Yawata S, Yamaguchi T, et al. Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors. Proc Natl Acad Sci USA 2013; 110:342-347.
67. Pertovaara A, Wei H. Dual influence of the striatum on neuropathic hypersensitivity. Pain 2008; 137:50-59. (Pubitemid 351794399)